• News
  • About the company
  • Investors & Media
  • Research and development
  • Generic Products
  • EN
    • PL
  • EN
    • PL
  • News
  • About the company
  • Investors & Media
  • Research and development
  • Generic Products

Celon Pharma S.A. begins a clinical programme for Esketamine in the treatment of drug-resistant depression

20171128_Celon Pharma S.A. begins a clinical programme for Esketamine in the treatment of drug-resistant depression

Ogrodowa 2A
05-092 Łomianki / Kiełpin

phone: +48 22 751 59 33

e-mail: [email protected]

NIP :118-16-42-061,
REGON : 015181033

Site Map

  • News
  • About the company
  • Requests for Proposals
  • Join us
  • Privacy policy
  • Report an adverse effect